10:44 PM IST
British drugmaker Vectura Group Plc said on Saturday that it won a patent infringement litigation case against GlaxoSmithKline Plc in the United States and has been awarded $89.7 million in damages for the period from August 2016 through December 2018.
A jury trial in a Delaware district court on Friday found that one of Vectura`s U.S. patents was infringed by sales of three of GSK`s Ellipta products in the United States, Vectura said.
The jury found that GSK, which is also a UK-based pharmaceutical company, willfully infringed the patent, which Vectura said gives it the right to seek enhanced damages.
Vectura expects to seek application of the 3 percent royalty to sales of the infringing products through the end of the patent term in mid-2021, it said.
Vectura started legal proceedings against GSK in July 2016 after a patent license agreement between the two companies expired and GSK declined to license additional patent families under the original agreement.
GSK did not respond to Reuters request for comment outside regular business hours.
(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
)
Rs 30,00,000 Lump Sum Investment in Mutual Fund: In how many years can you create a corpus of Rs 1 crore, Rs 2 crore & Rs 3 crore at 12% annual return?
)
Shares to Buy: Analysts recommend largecap, midcap stocks for short-term gains; Hyundai Motor, RBL Bank on the list
)
8th Pay Commission Pension Calculations: How your Rs 20,200, Rs 25,250, Rs 34,000, and Rs 44,200 basic pension can be revised at 2.10-2.50 fitment factors (detailed charts)
)
From Viral Fame to Police Warning: How this Mumbai auto driver went from earning lakhs to back on the road
)
How a 29-KM expressway transformed Gurugram’s real estate; these 4 areas are now hotspots for millionaires
)
Gratuity Calculation: What will be your gratuity for Rs 55,000, Rs 75,000, and Rs 95,000 last-drawn salary after 9 years and 4 months of service?
)
7 Stocks to buy for long term: Analysts recommend largecap, midcap stocks; Axis Bank, Ambuja Cements on the list
)
Monthly Income from One-time Investment: How your Rs 15,75,000 lump sum investment can generate Rs 2,74,500/month payout for 30 years
10:44 PM IST